246
Participants
Start Date
March 23, 2016
Primary Completion Date
June 11, 2019
Study Completion Date
August 19, 2019
Rivaroxaban
Rivaroxaban 15 mg twice daily for 21 days, followed by 20 mg once daily over a period of 3 months
low-molecular heparine
"LMWH in therapeutic dosage (1-2× daily s.c.) according to standards of the individual study center, using licensed dosages, e.g.~* Enoxaparin 1 mg/kg BW twice daily~* Tinzaparin 175 I.E./kg BW once daily~* Dalteparin 200 I.E./kg BW once daily"
Uniklinik, Aachen
Collaborators (1)
Charite University, Berlin, Germany
OTHER
Bayer
INDUSTRY
AIO-Studien-gGmbH
OTHER